Aerie Pharma (AERI) Tops Q3 EPS by 10c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. META
5. SPY
6. INTC
7. JBLU
8. ANT
9. NVDA
10. AAPL

Go back to Aerie Pharma (AERI) Tops Q3 EPS by 10c

Aerie Pharmaceuticals Reports Third Quarter 2015 Financial Results and Provides Business Update

November 3, 2015 4:01 PM EST

- Based on FDA Meetings, Company Expects to File RhopressaTM NDA in 3Q 2016 -

Conference Call and Webcast Today, November 3, at 5:00 p.m. ET

IRVINE, Calif.--(BUSINESS WIRE)-- Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, today reported financial results for the third quarter ended September 30, 2015, along with a general business update.

Aerie Highlights

... More